Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Addressing Healthcare Disparities and COVID-19 Concerns for All Patients with Multiple Sclerosis

Program Overview

This CME/CE symposium, led by Fred D. Lublin, MD, is derived from content presented at the Virtual ACTRIMS Forum in February, 2021. In this program, the expert faculty will review current disparities for the management of patients across the entire spectrum of disease with multiple sclerosis (MS). The faculty will discuss the immune-science relationship between COVID-19 infections and ...
View Course
Novel Targeted Therapies to Slow Disease Progression in Patients with Early-Stage Alzheimer’s Disease

Program Overview

This CE activity will highlight novel therapies to slow disease progression in patients with early-stage Alzheimer’s disease (AD), including data presented at the Virtual 13th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Digital Conference 2020. The expert faculty, led by Dr. Richard S. Isaacson, will first delve into the pathophysiology, early and accurate differential diagnosis and disease course ...
View Course
Anti-Programmed Cell Death (PD) Therapies for the Management of Patients with Lung Cancer

Program Overview

This CME program is derived from content presented at the 2020-2021 Eastern Pulmonary Conference Program. The expert faculty, Drs. Sidney S. Braman and M. Patricia Rivera, will first provide a review of current science in non-small cell lung cancer (NSCLC), including trends in stage distribution of lung cancer. Following, current data for targeted therapies as well as immunotherapies ...
View Course
Advances in Nontuberculous Mycobacterial Lung Disease: Improvement in Diagnosis, Treatment and Patient Quality of Life

Program Overview

This CME program is derived from content presented at the 2020-2021 Eastern Pulmonary Conference Program. The expert faculty, Drs. Sidney S. Braman and Charles L. Daley, will first highlight the prevalence and risk factors of nontuberculous mycobacterial lung disease (NTM-LD), as well as the importance of early diagnosis. Following, current criteria and treatment recommendations will be reviewed in ...
View Course
The Health-System Pharmacist’s Role in Providing the Most Effective Treatment for Patients with Hepatorenal Syndrome

Program Overview

This continuing education activity will highlight the health-system pharmacist’s role in providing treatment for patients with hepatorenal syndrome (HRS). The expert faculty will review the science, pathophysiology, and interplay between vasoconstrictor and vasodilator systems on the renal circulation in patients with hepatorenal syndrome type 1. Real-world data for new and emerging therapeutics in hospitalized patients with HRS type ...
View Course
Scientific Updates to Improve Outcomes in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis

Program Overview

This CME activity, derived from content presented at Maui Derm for Dermatologists 2021, will highlight recent advances in the treatment and management of moderate-to-severe atopic dermatitis, particularly in the adult patient population. The expert faculty, Drs. Jonathan Silverberg and Eric Simpson, will first review the immunopathology of atopic dermatitis, as well as current guidelines for both adolescents and ...
View Course

Upcoming Events

The Alliance 2022 Annual Conference

January 12th – 15th, 2022

Maui Derm for Dermatologists 2022

January 24th – 28th, 2022

Advanced Curriculum for Multiple Sclerosis 2022

February 22nd, 2022

2022 American Academy of Dermatology Annual Meeting

March 25th – 29th, 2022